Yaohua Fan*†1, Xiyan Zhu*1, Qiuping Lan*, Fang Lou*, Yu Zheng*, Haizhou Lou*, Yong Fang*, Wei Jin*, Hongming Pan*, Kaifeng Wang*‡
Oncology Research, Vol.23, No.5, pp. 219-228, 2015, DOI:10.3727/096504016X14567549091260
Abstract Radiofrequency ablation (RFA) is a minimally invasive technology for the treatment of liver malignancies
and is used as an adjuvant therapy in patients with colorectal liver metastasis (CLM). This study enrolled a
total of 49 CLM patients who underwent RFA treatment. Univariate and multivariate analyses were performed
using the log-rank test and Cox proportional hazard model, respectively. Univariate analysis showed that
OS was closely correlated with tumor size, frequency of RFA treatment, resection of the liver lesion, and
CEA levels before RFA (p<0.05). Multivariate analysis revealed that resection of CLM lesions after RFA,
frequency of RFA More >
Login
Register
